BBBY Stock Has Rallied 32% Over The Past Month — It Is Now Buying Fathom To Build A Homeownership Super App

Published : Jun 17, 2026, 07:00 PM IST
https://stocktwits.com/news-articles/markets/equity/bbby-stock-rallied-32-past-month-acquires-fathom-to-build-homeownership/cZK0UjFR7IA

Synopsis

The acquisition comes amid CEO Marcus Lemonis' efforts to transform the company beyond its retail roots.

  • Fathom operates a technology-driven real estate platform that combines residential brokerage, mortgage, title, insurance, and software services under a single umbrella.
  • Bed Bath & Beyond said those capabilities complement its existing "Everything Home" strategy and will help expand its Homeownership & Transactions business.
  • CEO Marcus Lemonis said the acquisition is intended to address what he views as a fragmented homeownership experience.

Bed Bath & Beyond Inc. (BBBY) announced on Wednesday that it has agreed to acquire Fathom Holdings Inc. (FTHM), a technology-driven real estate services platform, as the retailer accelerates its plan to build what it calls the nation's first end-to-end homeownership platform.

The acquisition comes as BBBY shares have surged 32% over the past month amid CEO Marcus Lemonis' efforts to transform the company beyond its retail roots and into a broader homeownership and home services platform.

Bed Bath & Beyond shares were down more than 5% in Wednesday’s pre-market trade, while Fathom shares soared nearly 88%.

Why FTHM Matters To BBBY

Fathom operates a technology-driven real estate platform that combines residential brokerage, mortgage, title, insurance, and software services under a single umbrella.

Bed Bath & Beyond said those capabilities complement its existing "Everything Home" strategy and will help expand its Homeownership & Transactions business.

CEO Marcus Lemonis said the acquisition is intended to address what he views as a fragmented homeownership experience.

“People buy homes from one company, finance them through another, furnish them through a third and renovate them with someone else. We believe homeowners deserve something better,” he said.

The Bigger Picture Of BBBY’s Strategy

Bed Bath & Beyond's broader strategy revolves around three pillars: Homeownership & Transactions, Omnichannel Commerce, and Home Services.

The company believes that combining those businesses into a unified platform will enable it to serve customers throughout the entire home lifecycle and create opportunities to cross-sell products and services.

Bed Bath & Beyond expects the Fathom acquisition to close in the second half of 2026, subject to regulatory approvals.

BBBY's Acquisition Spree Continues

The Fathom deal follows Bed Bath & Beyond's recent acquisition of Installed Right and SFV Services, two home-services businesses that provide installation, renovation, construction, and project-execution capabilities.

Announced earlier this month, Bed Bath & Beyond’s acquisition of Installed Right expands the company's Beyond Home Services platform.

What Do Retail Investors Think Of BBBY?

Retail sentiment on Stocktwits around Bed Bath & Beyond trended in the ‘bullish’ territory, while message volumes were at ‘high’ levels.

BBBY stock is up 10% year-to-date, while FTHM stock is down 37%. The iShares Micro-Cap ETF (IWC) is up 51% over the past 12 months, while the iShares Russell 2000 Value ETF (IWN) is up 40%.

For updates and corrections, email newsroom[at]stocktwits[dot]com.<

PREV

Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.

Recommended Stories

SpaceX Just Launched AST SpaceMobile's Biggest Bet To Advance Cell Service From Space
HIMS Stock Breaks Above $30 Ahead Of Upcoming FDA Peptide Review: Analysts Eye Next Growth Catalyst